Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 6.07 INR
Change Today 0.00 / 0.00%
Volume 0.0
As of 7:40 AM 04/4/14 All times are local (Market data is delayed by at least 15 minutes).

amar remedies ltd (AMAR) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/27/14 - 6.07
52 Week Low
08/27/14 - 6.07
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for AMAR REMEDIES LTD (AMAR)

Related News

No related news articles were found.

amar remedies ltd (AMAR) Related Businessweek News

No Related Businessweek News Found

amar remedies ltd (AMAR) Details

Amar Remedies Limited engages in manufacturing, trading, and marketing ayurvedic, fast moving consumer goods, and other products in India and internationally. It offers tooth pastes, tooth powders, tooth brushes, ointments, pain relief gels, cool talc products, soaps, pain relief balms, inhalers, petroleum jellies, shampoos, lotions, and creams. The company markets its products under the Amar, Smiles, and Fresh smiles brand names. Amar Remedies Limited was founded in 1984 and is headquartered in Mumbai, India.

Founded in 1984

amar remedies ltd (AMAR) Top Compensated Officers

Managing Director, Executive Director and Mem...
Total Annual Compensation: --
Non Executive Independent Director, Member of...
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

amar remedies ltd (AMAR) Key Developments

Amar Remedies Ltd. Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2013

Amar Remedies Ltd. reported unaudited standalone earnings results for the first quarter ended June 30, 2013. For the quarter, the company reported total income from operations (net) of INR 451.519 million against INR 1,810.93 million, loss from operations before other income, finance costs and exceptional items of INR 100.881 million against profit from operations before other income, finance costs and exceptional items of INR 330.481 million, loss from ordinary activities before tax of INR 288.623 million against profit from ordinary activities before tax of INR 166.781 million and net loss of INR 288.623 million or INR 11.03 basic and diluted per share against net profit of INR 102.141 million or INR 3.90 basic and diluted per share a year ago.

Amar Remedies Ltd. to Report Q4, 2013 Results on Aug 14, 2013

Amar Remedies Ltd. announced that they will report Q4, 2013 results on Aug 14, 2013

Amar Remedies Ltd., Board Meeting, Aug 14, 2013

Amar Remedies Ltd., Board Meeting, Aug 14, 2013. Agenda: To consider and approve the Unaudited Quarterly Financial Results for the quarter ended June 30, 2013.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMAR:IN 6.07 INR 0.00

AMAR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AMAR.
View Industry Companies

Industry Analysis


Industry Average

Valuation AMAR Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMAR REMEDIES LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at